SCHEMBL21982425

SCHEMBL21982425

C=NCc1ccc2c3c([nH]c2c1)C(C)(C)c1cc(N2CCN(C4CCC4)CC2)c(C2CC2)cc1C3=O

nearest known ligand 0.73

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 20/20 0.73
KDR P35968 3/20 0.59
INSR P06213 1/20 0.49
KIT P10721 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24675690 0.90 ALK (0.74) ALKKDRINSR
SCHEMBL20004172 0.87 ALK (0.61) ALKKDRINSRKIT
SCHEMBL7815503 0.86 ALK (0.78) ALKKDRINSRKIT
SCHEMBL24676762 0.85 ALK (0.75) ALKKDRINSRKIT
SCHEMBL896899 0.84 ALK (1.00) ALKKDRINSRKIT
Hydrochloric Acid SCHEMBL30730875 0.83 ALK (0.98) ALKKDRINSRKIT
Hydrochloric Acid SCHEMBL14990947 0.83 ALK (0.98) ALKKDRINSRKIT
SCHEMBL20004176 0.81 ALK (0.73) ALKKDRKIT
SCHEMBL20004735 0.80 ALK (0.77) ALKKDRINSRKIT
SCHEMBL20366537 0.79 ALK (0.76) ALKKDRKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10646468-B2 Composition comprising tetracyclic compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2020-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10646468-B2 Composition comprising tetracyclic compound ALK, ALPI, TTR ALK 1/4885KDR 71/4885INSR 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.